Ascending Single-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI-136 Administered Orally to Healthy Japanese Male Subjects and Healthy Japanese Elderly Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Jan 2010
At a glance
- Drugs GSI 136 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 15 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2008 New trial record.